<p>Manufacturers should focus on producing as many vaccines as possible this year, but the world faces a potential surplus next year in capacity, Moderna's CEO said on Friday.</p>.<p>Speaking at a virtual event on vaccine manufacturing, Stephane Bancel said that additional technology transfers might dent their ability to meet production targets. Moderna is on track to make up to 1 billion doses this year and 1.4 billion next year, he said.</p>.<p>"Next year there is going to be way too many vaccines for people on the planet," he said.</p>.<p>He added that Moderna was working hard to have a booster vaccine against Covid-19 variants approved by the northern hemisphere late summer or early autumn.</p>.<p>Bancel, asked about shortages of workers at the Lonza factory at Visp in the Swiss canton of Valais, which has a licence to make ingredients for its Covid-19 vaccine, but was confident that Lonza would close the gap there soon.</p>.<p>He also said that Moderna was in talks with the COVAX vaccine-sharing facility which is providing doses to lower income countries, adding: "I hope we are in the final stretch to get an agreement with COVAX."</p>
<p>Manufacturers should focus on producing as many vaccines as possible this year, but the world faces a potential surplus next year in capacity, Moderna's CEO said on Friday.</p>.<p>Speaking at a virtual event on vaccine manufacturing, Stephane Bancel said that additional technology transfers might dent their ability to meet production targets. Moderna is on track to make up to 1 billion doses this year and 1.4 billion next year, he said.</p>.<p>"Next year there is going to be way too many vaccines for people on the planet," he said.</p>.<p>He added that Moderna was working hard to have a booster vaccine against Covid-19 variants approved by the northern hemisphere late summer or early autumn.</p>.<p>Bancel, asked about shortages of workers at the Lonza factory at Visp in the Swiss canton of Valais, which has a licence to make ingredients for its Covid-19 vaccine, but was confident that Lonza would close the gap there soon.</p>.<p>He also said that Moderna was in talks with the COVAX vaccine-sharing facility which is providing doses to lower income countries, adding: "I hope we are in the final stretch to get an agreement with COVAX."</p>